FIGS, Inc. (NYSE:FIGS) Receives $18.71 Average Target Price from Brokerages

Shares of FIGS, Inc. (NYSE:FIGS) have been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $18.7143.

Several research analysts have weighed in on FIGS shares. Barclays boosted their price target on FIGS from $17.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, August 7th. BTIG Research lifted their price objective on FIGS from $20.00 to $22.00 and gave the company a “buy” rating in a research report on Friday, August 7th. KeyCorp lifted their price objective on FIGS from $19.00 to $20.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of FIGS in a research note on Friday, August 7th. Finally, Telsey Advisory Group reduced their target price on FIGS from $17.00 to $16.00 and set a “market perform” rating on the stock in a research report on Friday, August 7th.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in FIGS by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 77,219 shares of the company’s stock valued at $354,000 after purchasing an additional 3,276 shares during the period. Woodline Partners LP acquired a new position in FIGS during the first quarter worth approximately $3,199,000. Creative Planning raised its stake in FIGS by 181.3% during the second quarter. Creative Planning now owns 65,740 shares of the company’s stock worth $371,000 after purchasing an additional 42,367 shares during the period. Prudential Financial Inc. purchased a new position in FIGS during the second quarter worth approximately $70,000. Finally, Russell Investments Group Ltd. raised its stake in FIGS by 102.4% during the second quarter. Russell Investments Group Ltd. now owns 147,440 shares of the company’s stock worth $832,000 after purchasing an additional 74,578 shares during the period. 92.21% of the stock is currently owned by hedge funds and other institutional investors.

FIGS Price Performance

Shares of NYSE FIGS opened at $14.75 on Wednesday. The company has a 50-day simple moving average of $11.48 and a 200-day simple moving average of $12.72. The company has a market cap of $2.45 billion, a PE ratio of 44.70 and a beta of 1.03. FIGS has a 12 month low of $6.49 and a 12 month high of $17.48.

FIGS (NYSE:FIGS) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.08. The business had revenue of $196.62 million for the quarter, compared to the consensus estimate of $186.17 million. FIGS had a net margin of 8.72% and a return on equity of 12.53%. The company’s quarterly revenue was up 28.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.04 earnings per share. On average, analysts anticipate that FIGS will post 0.32 EPS for the current year.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.